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Objective: To evaluate the time-varying relationship of annual physical, psychiatric, and quality of life status with subsequent inpatient healthcare resource use and estimated costs. Design: Five-year longitudinal cohort study. Setting: Thirteen ICUs at four teaching hospitals. Patients: One hundred thirty-eight patients surviving greater than or equal to 2 years after acute respiratory distress syndrome. Interventions: None. Measurements and Main Results: Postdischarge inpatient resource use data (e.g., hospitalizations, skilled nursing, and rehabilitation facility stays) were collected via a retrospective structured interview at 2 years, with prospective collection every 4 months thereafter, until 5 years postacute respiratory distress syndrome. Adjusted odds ratios for hospitalization and relative medians for estimated episode of care costs were calculated using marginal longitudinal two-part regression. The median (interquartile range) number of inpatient admission hospitalizations was 4 (2-8), with 114 patients (83%) reporting greater than or equal to one hospital readmission. The median (interquartile range) estimated total inpatient postdischarge costs over 5 years were $58,500 ($19,700-157,800; 90th percentile, $328,083). Better annual physical and quality of life status, but not psychiatric status, were associated with fewer subsequent hospitalizations and lower follow-up costs. For example, greater grip strength (per 6 kg) had an odds ratio (95% CI) of 0.85 (0.73-1.00) for inpatient admission, with 23% lower relative median costs, 0.77 (0.69-0.87). Conclusions: In a multisite cohort of long-term acute respiratory distress syndrome survivors, better annual physical and quality S urvivors of acute respiratory distress syndrome (ARDS) frequently experience physical, psychiatric, and healthrelated quality of life (QOL) impairments (1) (2) (3) (4) (5) . Such impairments may impact long-term post-ARDS healthcare resource use and costs (6) (7) (8) (9) (10) , particularly in light of healthcare systems more frequently adopting postacute care bundled payments, or shared savings programs (11) . Understanding the relationship of these postdischarge impairments, especially in long-term survivors after ARDS, with subsequent resource use and costs over longitudinal follow-up is important for healthcare policy and planning (12) . Prior research in Canada found that follow-up hospitalization costs were highest in the first year after ARDS, and lower in subsequent years (1, 2) . We hypothesized that follow-up hospitalizations and skilled nursing and rehabilitation facility stays, and associated costs, would decrease over the course of 5-year, longitudinal follow-up after ARDS.
Using a multisite cohort of long-term ARDS survivors, our objective is to evaluate the relationship of time-varying, postdischarge measures of survivors' physical status, psychiatric symptoms, and QOL with subsequent annual hospitalization, and associated episode of care costs, over 5 years after ARDS.
MATERIALS AND METHODS

Study Cohort
This analysis focused on long-term ARDS survivors, defined as those surviving greater than or equal to 2 years after ARDS. Patients were recruited from the multisite Improving Care of Acute Lung Injury (ALI) Patients study that enrolled consecutive, mechanically ventilated patients with acute lung injury, determined by the American-European Consensus criteria (13) in effect during recruitment (14) . Consistent with the Berlin criteria (15) , hereafter, we use the term ARDS. Patients were enrolled from 13 ICUs at four teaching hospitals in Baltimore, MD, from 2004 to 2007, with follow-up ending in late 2012. Exclusion criteria are reported in the supplemental data (Supplemental Digital Content 1, http://links.lww.com/CCM/ C163). We obtained informed consent after decision-making capacity was regained (or via proxy if patient incapacitated). The study site institutional review boards approved this research.
Outcome Measures: Follow-Up Healthcare Resource Use and Costs
Healthcare resource data were collected for 5 years following ARDS. These data were collected via a one-time, retrospective structured interview completed for long-term survivors at 2-year follow-up, and then continued prospectively every 4 months to complete 5-year follow-up. The data collection instrument, adapted from a previous ARDS study (1) and similar to another widely used instrument (16) , collected data on follow-up inpatient care including: 1) hospitalizations, 2) skilled nursing facility stays, and 3) rehabilitation facility stays. Furthermore, during years 3-5, outpatient data were collected. We verified healthcare resource data via systematic medical record review at the three nonfederal study hospitals and at other facilities in the event of any patient/proxy uncertainty in self-report. We evaluated direct medical costs of healthcare resource use from the payer perspective. To evaluate the full economic burden associated with each follow-up hospitalization, we then calculated the "episode of care" cost that included costs of skilled nursing and rehabilitation facilities that were associated with follow-up hospitalizations (17 (23) . QOL was evaluated via the EuroQol 5-dimensions questionnaire (EQ-5D) Visual Analogue Scale (VAS) and utility score (24) , and Medical Outcomes Study short form-36 (SF-36) Physical and Mental Component Scores (PCS and MCS, respectively) (25) . Continuous measures were scaled by their estimated minimum important difference (MID) (i.e., 6MWD, EQ-5D utility score, SF-36 PCS and MCS, and HADS) (26) (27) (28) (29) or by one-half SD when MID data were not available (e.g., hand grip strength, EQ-5D VAS, and IES-R score) (30) .
Adjustment for Covariates: Baseline Patient and ICURelated Exposures
To evaluate the independent associations of the primary exposures with the outcomes, we adjusted for the following patient baseline and ICU-related exposures, selected, a priori, per existing literature and our prior study results (15) : gender, Charlson comorbidity index (31) , ICU length of stay (LOS) during index hospitalization, and time-varying measures of informal caregiver status (i.e., informal caregiver residing with the patient and providing assistance) and health insurance status (i.e., Medicare or Medicaid, private insurance, or no insurance). Insurance data at 1-year follow-up were imputed using pre-ARDS insurance status, as 1-year data were not collected.
Statistical Methods
Variables were compared for patients with versus without hospitalization over 5-year follow-up using chi-square (or Fisher exact tests) and t tests. Patients' follow-up inpatient care cost data include the following: 1) the presence or absence of an hospitalization in a given year and 2) among those with any hospitalizations in a given year, a positive skew in episode of care cost distribution. Consequently, we evaluated predictors of cost using a marginal longitudinal two-part regression model (8, 32) . First, a two-part "base model" was created including a main effect of time (continuous) and previously defined covariates. Second, to avoid overfitting, each of the 17 primary measures (e.g., measures of the physical, psychiatric, or QOL) was separately added to the "base model" to create 17 exposure models. The primary exposures were lagged so that the hospitalization and cost outcomes were evaluated with exposures reported from the prior year, for example, exposures measured at the end of year 1 were evaluated with costs during year 2. Each of the 17 primary exposure models was extended to include an interaction of the primary exposure and time. Statistical analyses were performed using Stata 13.1 (StataCorp, College Station, TX), SAS 9.4 (SAS Institute, Cary, NC; NLMIXED procedure with 10 quadrature points), and R statistical software (version 2.15.2; R Foundation for Statistical Computing, Vienna, Austria). A two-sided p value less than 0.05 was considered statistically significant.
RESULTS
Patient Pre-ARDS and ICU-Related Exposures
Of 142 2-year survivors, 138 (97%) completed the structured interview ( Fig. 1) . From these 2-year survivors, 124 patients survived to year 5, with 123 of 124 (99%) completing 5-year followup. In total, 114 of 138 2-year survivors (83%) reported greater than or equal to one hospitalization during 5-year follow-up. Comparing pre-ARDS characteristics with (n = 114) versus without (n = 24) follow-up hospitalizations, patients with hospitalizations had a higher proportion with Medicare or Medicaid insurance, lower physical function, and higher ICU illness severity during the index ARDS hospitalization ( Table 1) . (Table 2) .
Inpatient Resource Use
Estimated Costs of Inpatient Care
Hospitalization costs accounted for the majority (83%) of follow-up inpatient costs, with a median estimated hospitalization cost during 5-year follow-up of $57,500 (IQR, $25,500-150,100; 90th percentile, $278,400), whereas total inpatient followup (including hospitalizations, skilled nursing facility stays, and rehabilitation facility stays) costs were $58,500 ($19,700-157,800; 
Primary Exposures' Associations With Follow-Up Hospitalizations
Adjusting for baseline patient and ICU-related exposures and follow-up time, greater strength, physical functioning, and higher QOL measures at annual assessments were significantly associated with lower odds of hospitalization during the subsequent year (Table 3) , with odds ratios (95% CI) for hand grip strength of 0.86 (0.77-0.97; p = 0.013) per increase of 12% predicted, for 6-minute walk test of 0.94 (0.88-0.99; p = 0.025) per increase of 5% predicted, for EQ-5D utility score of 0.92 (0.87-0.98; p = 0.008) per increase of 0.07 points, and for SF-36 PCS of 0.85 (0.78-0.94; p = 0.001) per increase of five points. There were no significant associations of six measures of psychiatric symptoms with hospitalization (Table 3) . Similar findings were observed for postdischarge factors and estimated median episode of care costs (Table 3) (35) 11 (8) 6 (4) 9 (7) 7 (6) 66 (48) No. of admissions, median (IQR) 
Outpatient Resource Use and Cost
In regards to outpatient resource use during years 3-5, 127 of 138 2-year survivors (92%) visited a primary care physician. Specialist physicians were visited by 119 of 138 patients (86%). Psychiatry was the most commonly visited, with an annual average of 18% patients (25/138). Considering mental health providers more broadly (e.g., psychiatrist, psychologist, or counselor), an annual average of 40% (55/138) saw a mental health provider ( Table 4; and supplemental data [Supplemental Digital Content 1, http:// links.lww.com/CCM/C163]). In a subanalysis of postdischarge psychiatric symptoms exposures and outpatient mental health visits and costs, we found that depression, anxiety, and PTSD symptoms were all significantly associated with an increased odds of any outpatient mental health visit in the subsequent follow-up year, but only anxiety had a significant association with increased EQ-5D = EuroQol 5-dimension questionnaire, HADS = Hospital Anxiety and Depression Scale, OR = odds ratio, SF-36 = short form-36 questionnaire. a For each of the logistic and linear models, each postdischarge exposure was added separately to the same base model that adjusted for sex, informal caregiver status, insurance status, Charlson comorbidity index, ICU length of stay, and time (i.e., year of follow-up). b p values were calculated using multivariable logistic regression analysis of patients with any versus no hospitalization during each follow-up year. HosmerLemeshow test confirmed model fit. c p values were calculated using multivariable linear regression analysis of log-transformed yearly episode of care costs associated with each hospitalization, including the costs of skilled nursing and rehabilitation facility costs which were associated with hospitalizations (17) . d Grip strength, Impact of Event Scale-Revised (IES-R) score, and EuroQol 5-dimension questionnaire (EQ-5D)-Visual Analogue Scale are all scaled by one half of the SD (30) within this study cohort. e 6-min walk distance, Hospital Anxiety and Depression Scale (HADS), EQ-5D-utility score, short form-36 questionnaire Physical Component Score, and Mental Component Score were scaled by the reported minimally important difference (26) (27) (28) (29) . f Physical impairment was defined by ≥ 2 dependencies in independent activities of daily living. g Anxiety and depression symptoms defined by HADS scores ≥ 8. h Posttraumatic stress disorder defined by IES-R score ≥ 1.6. Boldface p < 0.05 were considered statistically significant.
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DISCUSSION
In this multisite, longitudinal, cohort study of long-term ARDS survivors, 83% had greater than or equal to 1 hospitalization with a median (IQR) of 4 (2-8) over 5-year follow-up, with annual median costs remaining stable, without decrease. Throughout follow-up, greater muscle strength, physical functioning, and related QOL scores, but not psychiatric symptoms, were consistently associated with fewer subsequent hospitalizations and lower associated healthcare costs.
This study is novel since prior studies have not evaluated the association of ARDS survivors' time-varying postdischarge status with their subsequent hospitalizations and associated costs (6, 9) . Hence, there can be limited comparison to prior literature. Compared to a Canadian ARDS study (1, 2), ours found higher mean annual costs, with inpatient costs greater than two-fold greater during the first year (i.e., $22,200 vs $10,000 per patient). Furthermore, costs decreased to $2,300 by year 5 in the Canadian study, while costs in our study remained stable, making our study costs 10-fold greater by year 5. Lower costs in the Canadian study are possibly due to fewer reported hospitalizations (8), differences in patients' pre-ARDS comorbidities and socioeconomic status, and differences in healthcare systems. A Canadian population-based study reported that ICU survivors had higher healthcare resource use, including more frequent hospitalization, compared to a control group of hospitalized noncritically ill patients (10) .
Among time-varying physical exposure variables, improved performance-based measures of strength and physical functioning, such as hand grip strength and 6MWD, had a Patients using, n (%) 16 (12) significant association with decreased odds of future hospitalizations and associated costs, whereas self-reported physical functioning measures (ADL and IADL) were not consistently associated. However, other self-reported measures (e.g., EQ-5D utility score and SF-36 PCS QOL instruments) were significantly associated with hospitalization and costs. These findings may have several explanations, including measurement differences (objective performance-based vs subjective self-reported measure), instrument scaling (e.g., ceiling/floor effect), and environmental effects incorporated in ADL and IADL measures, possibly modifying associations with resource use (3). Several postdischarge exposures had a significant interaction with time, with the relationship strengthening over time. While these interactions might be influenced by a survivor bias, a sensitivity analysis excluding patients who died during follow-up years 3-5 found no material changes. Although psychiatry was the most frequently visited outpatient specialty, only 39 of 624 hospitalizations (6%) had a psychiatric admission category. In addition, neither the SF-36 MCS nor any psychiatric measures (e.g., anxiety, depression, and PTSD symptoms) had significant associations with followup resource use. This is consistent with a medical-surgical ICU survivor study (37) , which found no association of 3-month postdischarge psychiatric symptoms and subsequent hospitalizations during 3-12 month follow-up. During years 3-5, the proportion of patients visiting a psychiatrist remained stable (16-21%), as did the proportion taking psychiatric medications (33-36%) (eTable 4, Supplemental Digital Content 1, http://links.lww.com/CCM/C163). In a population-based cohort study in Denmark (38) , ICU survivors had a cumulative incidence of psychiatric medication prescriptions of 19% that increased steadily over 1-year follow-up.
Studies evaluating readmissions following pneumonia and sepsis have commonly evaluated short-term 30-or 90-day readmission (39, 40) . Such studies reported, for example, that short-term readmissions are more frequent in a postsepsis population compared to nonsepsis patients (40, 41) . A study on sepsis survivors (42), reported year 1 costs were three-fold higher than years 2 and 3, contrasting with our finding that hospitalization costs remained fairly constant throughout follow-up.
Although there is evidence that rehabilitation can decrease resource use in other populations, for example, chronic obstructive pulmonary disease (43) , it remains unclear whether post-ICU interventions may decrease follow-up hospitalizations in ICU survivors. For example, although rehabilitation implemented early in the ICU may reduce resource use (44) (45) (46) , rehabilitation and other interventions after ICU discharge have not demonstrated the same benefit (47) (48) (49) . Further research is needed, focusing on interventions targeting muscle strength and physical functioning, based on the findings of this analysis.
Our study has potential limitations. First, we have no pre-ARDS comparison data for resource use and cannot determine if reported post-ARDS resource use is higher, directly attributable to the ARDS episode, or driven by other factors. Second, given the observational design, we cannot elucidate cause and effect relationships between the exposures and outcomes. Third, although the sample size is relatively large for a prospective longitudinal study, we may be underpowered to detect some exposure-outcome associations. Fourth, the healthcare resource use data for the first 2 years were collected by patient report of those patients surviving at least 2 years; therefore, the patient cohort evaluated long-term ARDS survivors without data on resource use of patients dying within 2 years post-ARDS. However, no difference in resource use predictors was found when patients dying during follow-up were excluded in a prior study (1) or in our sensitivity analysis excluding patients dying in years 3-5. In addition, given that data collected over the first 2 years were done via a onetime structured interview, recall bias may led to underestimated resource use, particularly in these first 2 years, that we attempted to address via performing systematic medical record verification. Fifth, costs may not be generalizable to other geographic areas as patients were enrolled from urban teaching hospitals in a single U.S. city and Maryland has a regulated all-payer payment system (50) . Therefore, evaluating patterns of healthcare resource use, rather than costs, may be more consistent for comparison. Sixth, we only have outpatient resource use data for years 3-5, limiting evaluation of these data. Finally, individual patient-level costs were not available for all postdischarge data; therefore, costs were estimated using established methods. It is possible that costs were underestimated because they are derived from pooled All Patient Refined Diagnosis Related Groups data, possibly diminishing the influence of extreme costs.
CONCLUSIONS
In conclusion, this longitudinal, 5-year follow-up study demonstrated that the vast majority of inpatient resource use for long-term survivors of ARDS are due to hospitalizations, with 83% of patients having greater than or equal to one follow-up hospitalization and half of patients having at least four hospitalizations during follow-up. Throughout 5-year follow-up, greater muscle strength, physical functioning, and QOL were consistently associated with fewer subsequent hospitalizations and lower associated costs. In ARDS survivors, the efficacy and cost-effectiveness of interventions aimed at improving strength and physical functioning should be further evaluated for their effect on reducing healthcare resource use and costs.
